Latest filing published 30 May 2025 for Checkpoint Therapeutics, Inc.. Read the official filing
No signal scores available.
Sharma Amit discloses dealings in Checkpoint Therapeutics, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 14 May 2024 to 28 May 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 30 May 2025 came the latest disclosure, a share grant in Checkpoint Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations